Cesca completes merger with TotipotentRX
Cesca Therapeutics, formerly ThermoGenesis (NASDAQ:KOOL), has completed a merger with TotipotentRX in exchange for approximately 12,490,800 shares. The merged company also changed its name to Cesca...
View ArticleAvita posts more positive ReCell trial results
Avita Medical (ASX:AVH; OTCQX:AVMXY) has reported new positive, statistically significant results in a ReCell Spray-on Skin trial with patients suffering with depigmented skin lesions. ReCell ReCell, a...
View Article
More Pages to Explore .....